Sarah Cannon Revenue and Competitors

Location

N/A

Total Funding

Research

Industry

Estimated Revenue & Valuation

  • Sarah Cannon's estimated annual revenue is currently $63.5M per year.(i)
  • Sarah Cannon's estimated revenue per employee is $127,500

Employee Data

  • Sarah Cannon has 498 Employees.(i)
  • Sarah Cannon grew their employee count by -5% last year.

Sarah Cannon's People

NameTitleEmail/Phone
1
Co-FounderReveal Email/Phone
2
Chief, Early-Phase Drug DevelopmentReveal Email/Phone
3
CEOReveal Email/Phone
4
Regional VPReveal Email/Phone
5
CEOReveal Email/Phone
6
Associate VP, Human ResourcesReveal Email/Phone
7
Associate Regional VPReveal Email/Phone
8
Regional VPReveal Email/Phone
9
Regional VP Oncology ServicesReveal Email/Phone
10
Regional VPReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$23M205N/AN/AN/A
#2
$2.1M29N/AN/AN/A
#3
$1.8M254%N/AN/A
#4
$22.2M198-3%N/AN/A
#5
$840.1M58836%N/AN/A
#6
$6M65N/AN/AN/A
#7
$1.9M26-10%N/AN/A
#8
$5.3M58-2%N/AN/A
#9
$20.2M18015%N/AN/A
#10
$5M54-25%N/AN/A
Add Company

What Is Sarah Cannon?

Sarah Cannon, the Cancer Institute of HCA Healthcare, offers integrated cancer services with convenient access to cutting-edge therapies for those facing cancer in communities across the United States and United Kingdom. Sarah Cannon's cancer programs include individualized patient navigation provided by oncology-trained nurses, more than 1,000 stem cell transplants performed annually throughout the Sarah Cannon Blood Cancer Network and molecular profiling capabilities. Through its services, Sarah Cannon is providing state-of-the-art cancer care close to home for hundreds of thousands of patients, a number unmatched by any single cancer center. To learn more about Sarah Cannon, visit sarahcannon.com.

keywords:Biotechnology,Healthcare,Pharmaceuticals

N/A

Total Funding

498

Number of Employees

$63.5M

Revenue (est)

-5%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Sarah Cannon News

2022-04-19 - New double-drug “wonder” therapy reignites hope of boosting lung cancer patients’ survival

... trial and life-changing for cancer patients,” said Tobias Arkenau, Consultant oncologist of the Sarah Cannon Research Institute UK.

2022-04-19 - Kinnate Biopharma Inc. Announces First Patient Dosed in Phase 1 Clinical Trial of its FGFR Inhibitor Product Candidate, KIN-3248

... said Benjamin Garmezy, MD, Assistant Director of Genitourinary Research for Sarah Cannon Research Institute at Tennessee Oncology.

2022-04-13 - Molecular Templates to Host Webinar on a Unique Approach to Immuno-Oncology for Solid Tumors

Event will feature a presentation by David Spigel, MD, chief scientific officer of the Sarah Cannon Research Institute.

2019-09-09 - Dr. Graff Underscores Unmet Needs in ESR1-Mutated Breast ...

Stephanie L. Graff, MD, director of the Breast Program at the Sarah Cannon Cancer Institute of HCA Midwest Health and associate director of ...

2019-09-03 - Crush the Crisis aims to take back unused opioid drugs

Medication can be turned in at Sarah Cannon Cancer Institute at Henrico Doctors' Hospital at 7607 Forest Ave. in Richmond, Spotsylvania ...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$168.1M4985%N/A
#2
$223.3M50619%N/A
#3
$92.3M509N/AN/A
#4
$153.3M51311%N/A
#5
$146.5M514-3%N/A